Bioderma’s iconic micellar water has become a cult favourite thanks to its gentle formula — and it’s now discounted at Boots ...

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in budoprutug Phase 1b/2a trial in ITP and Phase 1b trial in SLE; achieved ...

The Phase 2a trial enrolled 35 IPF patients randomized in a 2:1 ratio to receive either GRI-0621 or placebo once daily for 12 weeks. A sub-study examined immune cells in bronchoalveolar lavage fluid ...

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in ...

Investing.com -- FibroGen Inc (NASDAQ:FGEN) stock rose 5% on Wednesday after the company announced it would rebrand as Kyntra Bio, reflecting its sharpened focus on oncology and rare disease therapies ...

Karnataka High Court held that flavoured milk should be classified under Tariff Heading 0402 of the Customs Tariff Act and ...

Investing.com -- Instil Bio (NASDAQ:TIL) stock fell 15% Tuesday after the company announced that its wholly-owned subsidiary Axion Bio has decided to discontinue clinical development of AXN-2510 and ...

Investing.com -- Cable One, Inc. (NYSE:CABO) stock rose 3.6% in after-hours trading on Monday following the announcement that it will acquire the remaining 55% stake in Mega Broadband Investments ...

Investing.com -- Kala Pharmaceuticals Inc (NASDAQ:KALA) stock surged 14% in after-hours trading Monday following the company’s announcement that it has successfully settled its debt obligations with ...

Browns rookie Carson Schwesinger reflects on his breakout season after emerging as a Defensive Rookie of the Year contender.

Dr. Christian Loss, Chief Executive Officer (CEO) of Neovii Pharmaceuticals AG, will take a well-deserved retirement after his distinguished career at Neovii. As of January, he is succeeded by ...

ICHIRAN Original Shop and Headquarters in Fukuoka serves its signature tonkotsu ramen 24/7, with a nightly 8 pm dance unique ...